Shockwave Medical Announces CE Mark Approval of its Lithoplasty System for the Treatment of Peripheral Artery Disease

Shockwave Medical, a pioneer in the treatment of advanced peripheral and coronary vascular disease, today announced CE Mark regulatory approval for the company’s Lithoplasty™ ballo



from Content Keyword RSS http://ift.tt/1wpPAHH

via IFTTT